Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2156 (LINC02156)

Target
LINC02156
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Other (non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 2156 (*LINC02156*) is classified as a long intergenic non-coding RNA (lincRNA), which refers to autonomously transcribed RNA molecules over 200 nucleotides in length that do not overlap with protein-coding genes[1]. Like other lincRNAs, LINC02156 belongs to the broader long non-coding RNA (lncRNA) family, a large and diverse group of RNAs with key roles in chromatin remodeling, regulation of gene transcription, and genome architecture[1]. LincRNAs often act as regulators of neighboring or distant genes through complex mechanisms, including both sequence-dependent and sequence-independent processes, and may exert tissue-specific effects[1]. Despite the rapidly growing recognition of their biological importance, detailed, experimentally confirmed functions for most lincRNAs—including LINC02156—have not yet been established; there is currently no evidence that LINC02156 is a receptor, enzyme, transporter, or direct therapeutic target[1]. There are also no specific data available regarding drugs, mechanism of drug action, biomarker use, or known safety concerns for LINC02156. *Note: All information provided is based on current knowledge about the lincRNA class and naming conventions; specific functional or disease association data for LINC02156 are currently lacking.*

Other names
RP1-90J4.1LINC02156
02

Biological functions

Transcription regulation (of other genes in *cis* or *trans*)[1]Chromatin remodeling and genome architecture[1]RNA stabilization[1]Potential enhancer-associated activity[1]Other: Many lincRNAs function in fine-tuning gene expression, often with tissue specificity[1]
03

Disease associations

Other (General lincRNA literature indicates roles in diseases, including cancer, but there is no specific evidence that LINC02156 itself is linked to disease as of now)[1]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2156 (LINC02156).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2156 (LINC02156).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call